MYELOMA December 3, 2024 by Steve Bryson, PhD New atlas details immune cell changes as disease progresses Researchers in Belgium have developed an atlas to mark changes in distinct types…
MYELOMA November 26, 2024 by Margarida Maia, PhD FDA to review combinations of Blenrep for multiple myeloma The U.S. Food and Drug Administration (FDA) will review GSK’s request to approve…
November 19, 2024 by Marisa Wexler, MS Survival better with Blenrep combo than Darzalex for R/R myeloma A combination therapy using Blenrep (belantamab mafodotin) was more effective at extending life in…